
MRNS
Healthcare · Biotechnology · $30.4M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2024 | Before the open | -0.41 | -0.42 | -2.4% |
| Aug 13, 2024 | Before the open | -0.59 | -0.60 | -1.7% |
| May 8, 2024 | Before the open | -0.66 | -0.68 | -3.0% |
| Mar 5, 2024 | After the close | -0.62 | -0.74 | -19.4% |
| Nov 7, 2023 | Before the open | -0.66 | -0.61 | +7.6% |
| Aug 10, 2023 | Before the open | -0.72 | -0.61 | +15.3% |
| May 11, 2023 | Before the open | -0.72 | -0.67 | +6.9% |
| Mar 7, 2023 | After the close | -0.70 | -0.76 | -8.6% |
| Nov 7, 2022 | After the close | 0.47 | -0.94 | -300.0% |
| Aug 11, 2022 | Before the open | -0.69 | -1.06 | -53.6% |
| May 12, 2022 | After the close | -0.85 | -0.52 | +38.8% |
| Mar 21, 2022 | Before the open | -0.76 | -0.77 | -1.3% |
| Nov 9, 2021 | Before the open | -0.73 |
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY (ganaxolone), an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic…
| -0.53 |
| +27.4% |
| Aug 10, 2021 | Before the open | -0.69 | -0.65 | +5.8% |
| May 17, 2021 | Before the open | -0.45 | -0.74 | -64.4% |
| Mar 9, 2021 | Before the open | -0.51 | -0.55 | -7.8% |
| Nov 9, 2020 | After the close | -0.60 | -0.51 | +15.0% |
| Aug 6, 2020 | Before the open | -0.75 | -0.64 | +14.7% |
| May 4, 2020 | Before the open | -0.64 | -0.88 | -37.5% |
| Mar 16, 2020 | Before the open | -0.83 | -1.00 | -20.5% |
| Nov 6, 2019 | Before the open | -0.95 | -1.04 | -9.5% |
| Aug 8, 2019 | Before the open | -0.95 | -0.96 | -1.1% |
| May 1, 2019 | Before the open | -0.86 | -0.96 | -11.6% |
| Mar 11, 2019 | Before the open | -1.02 | -1.00 | +2.0% |
| Oct 29, 2018 | Before the open | -0.84 | -1.08 | -28.6% |
| Aug 2, 2018 | Before the open | -0.62 | -0.96 | -54.8% |
| May 2, 2018 | Before the open | -0.65 | -0.60 | +7.7% |
| Mar 6, 2018 | Before the open | -0.62 | -0.80 | -29.0% |